Aelan Cell Technologies, founded by Dr. Victoria Lunyak, is engaged in the research, discovery, development and commercialization of innovative biomedical technologies for the advancement of human health and longevity. On July 6, 2016 Aelan Cell Technologies announced they were developing a novel biomarker for Alzheimer’s disease. Aelan also has an interest in developing a range of stem cell technologies.
×
Aelan Cell Technologies � Alzheimer's biomarker
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD